BioNTech SE ADR Stock
Price
Target price
€92.55
€92.55
2.720%
2.45
2.720%
€124.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock BioNTech SE ADR is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for BioNTech
sharewise wants to provide you with the best news and tools for BioNTech, so we directly link to the best financial data sources.
Financials
News
BioNTech Stock: Strategic CureVac Acquisition Fuels Cancer Push
BioNTech has unveiled plans to acquire former rival CureVac in a stock-based transaction valuing the Tübingen-based company at approximately $1.25 billion (€1.08 billion). This strategic move
BioNTech Stock: Q1 Losses Deepen Amid Leadership Change
BioNTech slipped deeper into the red during the first quarter of 2025, reporting a net loss of €415.8 million, significantly worse than the €315.1 million loss recorded in the same period last year
BioNTech Stock: Legal Setback in Moderna Patent Dispute
BioNTech faces a significant legal defeat as the Düsseldorf Regional Court ruled in favor of Moderna in a patent infringement lawsuit related to COVID-19 vaccine development. The Mainz-based company